(Q51809320)
Statements
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. (English)
1 reference
E Brini
1 reference
F Ruffini
1 reference
A Bergami
1 reference
E Brambilla
1 reference
G Dati
1 reference
B Greco
1 reference
R Cirillo
1 reference
A E I Proudfoot
1 reference
G Comi
1 reference
P Zaratin
1 reference
G Martino
1 reference
15 February 2009
1 reference
209
1 reference
1-2
1 reference
33-39
1 reference